(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 2. XRAR
2.2 loss-of-function leads to axial truncations and reduction of
HOXB9 expression. (A-D) Microinjection of RAR-MO causes anterior and
posterior truncations at highest frequency when expressed in the head region
(A) or dorsally (B). (C) Phenotypes are mild to undetectable when the lineage
tracer is distributed laterally or ventrally. (D) Phenotypes are rescued by
co-injection of XRAR
2 mRNA, irrespective of where the
lineage tracer is located. (E,F) Neither XBRA (E) nor XWNT8
(F) expression is affected by RAR-MO injection. (G-K) Effects of RAR-MO on the
expression of HOXB9. (H-J) The types of phenotypes obtained. (K)
HOXB9 expression was restored by co-injecting XRAR mRNA and
RAR-MO.